Virus-induced autoimmune disease

Current Opinion in Immunology

Volumn 8, Issue 6, 1996, Pages 878-885

  Von Herrath, Matthias G ^a   Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CYTOKINE; GAMMA INTERFERON;

ANIMAL MODEL; AUTOIMMUNITY; ETIOLOGY; GENETIC PREDISPOSITION; IMMUNOLOGICAL TOLERANCE; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; REVIEW; VIRUS GENE; VIRUS INFECTION;

EID: 0030459470     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80019-7     Document Type: Article

References (73)

1. Bach J-F: Predictive medicine in autoimmune diseases: from the identification of genetic predisposition and environmental Influence to precocious immunotherapy. Clin Immunal Immunopath 1994, 72:156-161.
2. Theophilopoulos A: The basis of auto immunity: part II, genetic predisposition. Immunol Today 1995, 16:150-159.
3. Tisch R, McDevitl H: Insulin-dependent diabetes mellltus. Ce" 1996, 85:291-297.
4. Ebers G, Bulman D, Sadovnik A, Paty D, Warren S, Hader W, Murray T, Ssland T, Duquette P, Grey T: A population based study of multiple sclerosis in twins. N Engl J Med 1987, 315:1638-1642.
5. Miller S, Karpus WJ : The immune pathogenesis and regulation of T-cell mediated demyelinating diseases. Immune! Today 1994, 15:358-362.
6. Schatz D, Krischer J, Horne G, Rilay W, Spillar R, Silverstein J, Winter W, Muir A, Darovanesian D, Shah S et al.: Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected reletives. J Clin Invest 1994, 93:2403-2407.
7. Aichele P, Kyburz D, Ohiashi P, Odermall P, Zinkernagel RM, Hengartner H, Pircher HP: Peptide induced T-cell tolerance to prevent autoimmune diabetes in a tg mouse model. Proc Natl Acad Sci USA 1994, 91:444-448.
8. Weiner HL, Friedmari A, Miller A, Khoury SJ, Al-Sabbagh A, Sanlos L, Sayegh M, Nussenblatt RB, Trantham DE, Hafler DA: Oral tolerance: immunologie mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994, 12:809-837.
9. Tisch R, McDevitt H: Antigen specific immunotherapy: is it a real possibility to combat T-cell medicated autoimmunity? Proc Natl Acad Sci USA 1994, 91:437-438.
10. Merriman TR, Todd JA: Genetics of autoimmune disease. Curr Opin Immunol 1995, 7:786-792.
11. Panitch HS: Influence of infection on exacerbations of multiple sclerosis. Ann Neurol 1994, 36:525-28.
12. Andersen O, Lygner PE, Bergstrom T, Andersson M, Varilne A: Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol 1993, 240:417-422.
13. Utz U, Biddison WE, McFarlane HF, McFarlin DE, Flerlage M, Martin R: Skewed T-cell receptor repertoire in genetically identical twins correlates with MS. Nature 1993, 364:243-247
14. Green A: The role of genetic factors in development of IDDM. Curr Top Microbiol Immunol 1990, 164:3-17.
15. Berdanier CD: Diet, autoimmunity, and insulin-dependent diabetes mellitus: a controversy. PSEBM 1995, 209:223-230.
16. Dahlquist G, Frisk G, Ivarsson SA, Svanberg L, Forsgren M, Diderholrn H: Indications that maternal coxsackie B virus Infection during pregnancy is a risk factor for childhood-onset IDDM. Diabetologis 1995, 38:1371-1373
17. 7. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schjltz ER, Bennett JL, Garber RL, Chang M: Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Prcc Natl Acad Sci USA 1995, 92:7440-7444.
18. Vento S, Guella L, Mirandola F, Cainelli F, Di Perri G, Solbiati M, Ferraro T, Concia EX: Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals. Lancet 1995, 346:608-609.
19. Oldstane MBA: Molecular mimicry as a mechanism for the cause and as a probe uncovering etiologic agent(s) of autoimmune disease. Curr Top Microbiol Immunol 1989, 145:127-135.
20. Conrad B, Weidmann E, Trucco G, Rudert WA, Behboo R, Ricordi C, Rodriquez-Rilo H, Ginegold D. Trucco M: Evidence for su per antigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 1994, 371:351-355.
21. Baum H, Davies H, Peakman M: Molecular mimicry in the MHC: hidden clues to autoimmunity? Immunol Today 1996, 17:64-71. In this article, Baum et al. present a novel hypothesis for how molecular mimicry may be implicated in the development of autoimmune diseases. They postulate that self-MHC peptides presented in the thymus can determine which mimicking peptides elicit an immune response and in this way define the potential for autoimmune disease.
22. Oldstone MBA: Molecular mimicry and autoimmune disease. Cell 1987, 50:819-820.
23. Garza KM, Tung KS: Frequency of molecular mimicry among T cell peptides as the basis for autoimmune disease and autoantibody induction. J Immunol 1995, 155:5444-5448.
24. Sirvestris F, Williams RC Jr, Dammacco F: Autoreactlvity In HIV-1 infection: the role of molecular mimicry. Clin Immunol Immuncpathol 1995, 75:197-205.
25. Wucherpfennig KW, Stromingsr JL: Molecular mimicry in T-cell mediated autoimmunity: Viral peptides activate human T-cell clones specific for myelln basic protein. Cell 1995, 80:695-705. This study shows that MBP-reactive T-cell clones isolated from patients with MS can cross-react with a variety of infectious agents, thus implicating 'molecular mimicry' directly in the pathogenesis of MS.
26. Wucherpfennig KW, Yu B, Bhol K, Monos DS, Argyris E, Karr RW, Ahmed AR, Strominger JL: Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Pmc Natl Acad Sci USA 1995, 92:11935-11939.
27. Sprent J, Webb S: Intrathymic and extrathymic deletion of T-cells. Curr Opin Immunol 1995, 7:196-205.
28. Ashton-Richardt PA, Bandeira A, Delanay J, Van Kaer L, Pircher HP, Zinkemagel RM, Tonegawa S: Evidence for a differential avidity model of T-cell selection in the thymus. Cell 1994, 76:651-663.
29. Genain C, Lee-Parritz D, Nguyen M, Massacesi L, Joshi N, Ferrante R, Hoffman K, Moseley K, Latvin N, Hauser S: In healthy primates, circulating autoreactive T-cells mediate autoimmune disease. 1 Clin Invest 1994, 94:1339-1345.
30. Moudgil KD, Sercarz EE: The T cell repertoire against cryptic self determinants and its involvement in autoimmunity and cancer. Clin Immunol Immunopath 1994, 74:283-289.
31. Heath WR, Karamalis F, Donoghue J, Miller JF: Autoimmunity caused by ignorant CD8+ T cells is transient and depends on avidity. J Immunol 1995, 155:2339-2349.
32. Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H: Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991, 65:319-331.
33. Ohashi P, Oehen S, Buerki K, Pircher H, Ohashi C, Odermatt B, Maliseen B, Zinkernagel R, Hengartner H: Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice. Ceff 1991, 65:305-317.
34. Tough DF, Borrow P, Sprent J: Induction of bystander T cell proliferation by viruses and type 1 Interferon in vivo. Science 1996, 272:1947-1950. This article demonstrates that viral infections and IFN secretion can lead to activation of memory cells, which could be implicated in the maintenance of memory as well as induction of autoreactive lymphocytes.
35. Bhardwaj V, Kumar V, Geyser HM, Sercarz EE: Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. J Immunol 1993, 151:5000-5010.
36. Selin L, Nahill S, Welsh R: Cross-reactivities in memory CTL recognition of heterologous viruses. J Exp Med 1994, 179:1933-1943.
37. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, MacLaren NK: Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus In Insulin-dependent diabetes. J Clin Invest 1994, 94:2125-2129.
38. Albani S, Keystone J, Nelson J, Ollier W, LaCava A, Montemayor A, Weber C, Montecucco A, Martini D, Carson D: Positive selection in autolmmunity: abnormal immune responses to a bacterial DNAJ antigenic determinant In patients with early RA. Nat Med 1995. 1:446-452.
39. Tuckova L, Tlaskalova M, Faire K, Krashka P, Rossmann P, Kolinska J, Kocna P: Molecular mimicry as a possible cause of autoimmune reactions in celiac diease? Clin Immunol Immunopath 1995, 74:170-176.
40. Notkins AL, Yoon JW Virus induced diabetes meltitus. In Concepts in Viral Pathogenesis. Edited by Notkins A, Oldstone M. New York: Springer Verlag; 1984:241-247.
41. Shrinivasappa J, Saegusa J, Prabhakar B, Gentry M, Buchmeier M, Wiktor T, Koprowski H, Olstone M, Notkins A: Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J Virol 1986, 57:397-401.
42. Sorbel RA: The pathology of multiple sclerosis. J Virol 1995, 13:1-21.
43. Hollsberg P, Hafler DA: What is the pathogenesis of human T-cell lymphotropic virus type l-associated myelopathy/tropical spastic peraparesis? Ann Neurol 1995, 37:143-145.
44. Banki K, Colombo E, Sia F, Halladay D, Mattsori DH, T alum AH, Massa PT, Phillips PE, Pari A: Oligodendrocyte-specific expression and autoantiganicity of transaldolase in multiple sclerosis. J Exp Med 1994. 180:1649-1663.
45. Wagner B, Vierhapper H, Holmann H: Prevalence of hepatitis C virus infection In Hashimoto's thyroiditis. BMJ 1996, 312:640-641.
46. Lawson CM, O'Donoghue HL, Reed WD; Mouse cytomegalovirus infection induces antibodies which crossreact with virus and cardiac myosin: a model for the study of molecular mimicry in the pathogenesis of viral myocarditis. Immunology 1992, 75:513-519.
47. Di Mario Veronese F, Arnott D, Barnaba V, Loftjs DJ, Sakaguchi K, Thompson CB, Salemi S, Mastroianni C, Sette A, Shabanowitz J et al.; Autoreactive cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected subjects. J Exp Med 1996. 183:2509-2516.
48. Talbot JP, Paquette JS, Ouallet F, Antel JP: T cells cross-reactive to myelin basic protein and human respiratory coronavirus 229E in multiple sclerosis patients. Neurology 1995,45:1383-1384.
49. Talbot JP, Paquette JS, Ciurli C, Ante! JP, Quellet F: Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Ann Neurol 1996, 39:233-240.
50. Oldstone MBA, Lewicki H, Borrow P, Hjdrisier D, Gairin JE: Discriminated selection among viral peptides with the appropriate anchor residues: implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection. J Virol 1995, 69:7423-7429.
51. b molecules are restricted by dominant negative elements at peptide non-anchor residues. J Biol Chem 1996, 271:17829-17836. This study shows that, although there exists a large variety of viral peptides with the correct MHC binding motif, only very few can be presented by APCs. This is a consequence of the influence of nonanchoring residues.
52. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernandez-Sueiro JL, Balish E, Hammer RE: The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenlc rats. J Exp Med 1994, 180:2359-2364.
53. Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM: Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993, 72:551-560
54. Morgan D, Liblau R, Scott B, Fleck S, McOevitt HO, Sarfetnick N, Lo D, Sherman L: CDB+ T cell-mediated spontaneous diabetes in neonatal mice. J Immunol 1996, 157:978-984. The authors demonstrate that transgenic mice that express influenza hemaglutinin (HA) in their β-cells and are normally tolerant to the transgene, all develop spontaneous diabetes, when the number of autoreactive T cells is increased by mating these mice to TCR transgenic mice bearing a TCR specific for HA.
55. Von Herrath MG, Dockler J, Oldslone MBA: How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in transgenic model. Immunity 1994, 1:231-242.
56. Kagi D, Odermall B, Ohashi PS, Zirikarnagel RM, Hengartner H: Development of in su lit s without diabetes in transgenic mice lacking petforin-dependent cytotoxicity. J Exp Med 1996, 183:2143-2150.
57. Vor Herrath MG, Dockter J, Nerenberg M, Gairin JE, Oldstone MBA: Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus. J Bip Med 1994, 180:1901-1910.
58. Tishon A. Lewicki H, Rail G, Von Herrath MG, Oldstone MBA: An essential role for type 1 Interferon-/ in terminating persistent viral infection. WrcWogy 1995, 212:244-250.
59. + cytotoxic T-cell responses during chronic viral infection. J Virol 1994, 66:8056-8063.
60. Von Herrath MG, Yokoyama M, Dockter J, Oldstone MBA, Whitton JL : CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J Virol 1996, 70:1072-1079.
61. Von Herrath MG, Guerder S, Lewicki H, Flavell R, Oldslone MBA: Coexpression of B7.1 and viral (self) transgenes in pancreatic β-cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity 1995, 3:717-738. This article provides evidence from tne RIP-LCMV model for the regulatory role of cytokines in the pathogenesis of IDDM. Furthermore, trie correlation between numbers of autoreactive lymphocytes and ths incidence of virusinduced IDDM is demonstrated.
62. Lau L, Jamieson BD, Somasundaram T, Ahmed R: CTL memory without antigen. Nature 1994, 369:646-652.
63. Guerder S, Picarella DE, Linsley PS, Flavell RA: Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor a leads to autoimmunity in transgenic mice. Proc Natl Acad Sci USA 1994, 91:5138-5142.
64. Ohashi P, Oehen S, Aichele P, Pircher H, Odermatt B, Herrera P, Higiichi Y, Suerki K, Hengartner H, Zinkernagel RM: Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and TNF-alpha. J Immunol 1993, 150:319-331.
65. Charllon B, Lafferty KJ: The Th1/Th2 balance in autoimmunity. Curr Opin Immunol 1995, 7:793-798.
66. Lee MS, Von Herrath M, Reiser H, Oldstone MBA, Sarvetnick N: Sensitization to self antigens by in situ expression of interferon-y. J Clin fa/asf 1995, 95:486-492. This article shows that local inflammation induced by a cytokine such as interferon-y can lead to the spontaneous activation of autoreactive lymphocytes and autoimmune disease (IDDM).
67. Von Herrath M, Allison J, Miller JFAP, Oldstone MBA: Focal expression of IL-2 does not break unresponsiveness to 'self (viral) antigen expressed in β-cells but enhances development of autoimmune disease (diabetes) after initiation of an antiself immune response. J Clin Invest 1995, 95:477-485.
68. Myung-Shik L, Von Herrath MG, Sawyer S, Arnush M, Krahl T, Oldstone MBA, Sarvetnick N: TGF-β fails to inhibit allograft rejection in transgenic mice. Transplantation 1996, 7:1-10.
69. Mueller RT, Sarvetnick N: Pancreatic expression of IL-4 abrogates insulitis and diabetes in NOD mice. J Exp Med 1996, in press. This is the first demonstration that by using localized cytokine expression autoreactivity can be diverted and autoimmunity prevented.
70. Panina-Bordignon P, Lang R, Van Ended PM, Benazzi E, Felix AM, Pastore RM, Spinas GA, Sinigaglia F: Cytotoxic T cells specific for glutamic acid decarboiylase in autoimmune diabetes. J Exp JWed 1995, 181:1923-1927
71. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM: Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993, 362:758-761.
72. Von Herrath MG, Dyrberg T, Oldstona MBA: Oral insulin treatment prevents virus-induced IDDM. J Clin Invest 1996, 98:1324-1331.
73. Fruh K, Kwangseog A. Peterson PA: Inhibition of MHC class I antigen presentation by viral proteins. Mol Med 1996, in press.